Galmed Hosting KOL Symposium and Pipeline Update

Author's Avatar
Jan 19, 2021
Article's Main Image

Aramchol Phase 3 Trial for Non-Alcoholic Steatohepatitis and Liver Fibrosis

Amilo-5MER for Chronic Inflammatory Disorders

Symposium Being Held January 26th at 11am Eastern Time

PR Newswire